[New developments in extemporaneous formulations].
Dermatology is in a state of flux, and systemic therapies have changed the prescription practice in the past few years. Nevertheless, topical therapy for dermatological illnesses is still the mainstay of dermatologists. Pharmaceutically manufactured drugs have a wide spectrum and allow for variability. Additionally, there are therapeutic niches that can be bridged by prescribing extemporaneous formulations. This is also true for the newly established basic therapies for many chronic dermatological illnesses which have become essential and are needed in large amounts. Unfortunately, neither during medical school, nor during residency training, not even the basic knowledge or the complexity of these extemporaneous formulations for topical therapy in dermatology is taught. This emphasizes why standardized, proven extemporaneous formulations are vital for physicians to achieve optimal and goal-oriented therapy for their patients. Sensible and effective prescriptions enhance the quality of formulations and the maintenance and well-being of our patients.
Hautklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland. petra.staubach@unimedizin-mainz.de.
P
P
Staubach
DAC/NRF, Avoxa - Mediengruppe Deutscher Apotheker, Eschborn, Deutschland.
S
S
Melhorn
DAC/NRF, Avoxa - Mediengruppe Deutscher Apotheker, Eschborn, Deutschland.|Löwen Apotheke Naumburg, Gesellschaft für Dermopharmazie, Fachgruppe Magistralrezepturen, Naumburg, Deutschland.
A
A
Hünerbein
Hautklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland.
A
A
Peveling-Oberhag
D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000138:chemical synthesis*; D004339:Drug Compounding / Q000639:trends*; D011307:Drug Prescriptions; D019317:Evidence-Based Medicine; D005858:Germany; D006801:Humans; D012871:Skin Diseases / Q000188:drug therapy*; D016896:Treatment Outcome
D003879:Dermatologic Agents
Basic therapy; Compounding; Dermatology; Extemporaneous formulations; Plausibility check